Annual Meeting 2022: Advancing Precision Immuno-oncology
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
As we finally welcome spring, enjoy this hand-picked selection of articles brought to you by the editors of the...
In 2015, NFL running back Brandon Bolden was having an incredible season with the New England Patriots. That year,...
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
For the first time since 2019, the American Association for Cancer Research (AACR) Annual Meeting is set to return...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today The nationwide shutdown of elective clinical procedures implemented in...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...
Tuesday, March 8, marked International Women’s Day, a global celebration of the social, economic, cultural, and political achievements of...
This year, the American Association for Cancer Research (AACR) will celebrate its 115th birthday. From the very beginning, women...